Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Kaboom!!! ARYC up 30% today !!! Penny Traders Club!!
PLSB into next week: huge technical break coming: low OS Bev play with great fundamentals.
PLSB Market Value1 $555,000 a/o Jun 30, 2017
Outstanding Shares 252,533,022 a/o May 04, 2017
Reported Revs = 3mils/yr avrg
Storng distribution: 75 of its strongest Class “A” DSDs and 20 wholesalers, concentrating placements into high volume cold box sets. During this time Pulse eliminated a number of weaker, non-performing DSDs
over 25,000 retail distribution outlets to date, supplied by ClassA's network like: Kehe, Mahanska, Affiliated Foods, Sysco, The Sygma Network, UNFI and distributors for Anheuser Busch, Miller Coors, Pepsi, Coca-Cola, RC/7-Up and Cadbury Schweppes.
$NOUV - Monstrous Acquisition News!!!
Nouveau Life Pharmaceuticals Acquires Smartco Energy Inc.
Jun 28, 2017
OTC Disclosure & News Service
Daytona Beach, FL -
Nouveau Life Pharmaceuticals, Inc. (OTC PINK: NOUV) announced today that it has acquired all of the shares of Smartco Energy Inc. ("SMARTCO") in its first step to implement its strategy to capitalize on the ESCO market. http://www.smartcoenergy.com ;
Smartco has structured itself as a one-stop for energy savings for both commercial and residential applications. It is in the process of establishing exclusive selling territories and management has forged relationships with key best in class service providers to implement energy savings solutions with companies such as Calpine for energy distribution, Kvar for peak load reductions, Roomcheck for hotel packages, Invivid for LED lighting, Wireless Controls Group for outdoor lighting and Entuit for indoor controls and HVAC controls.
"With the structure in place, we are now ready to build out our territories. I believe strongly we are in the right market at the right time to develop an aggressive marketing campaign similar to a franchise model in 480 territories. We can provide the one-stop shop solution and we have been approached from several entities that are ready to sign up, get trained and start selling," stated Jeff Burns, CEO of Nouveau Life Pharmaceuticals, Inc.
The Company is also in the process of finalizing paperwork to change its name from Nouveau Life Pharmaceuticals to better reflect is business strategy and operations.
Forward-Looking Statements - This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause future results to differ materially from the forward-looking statements. You should consider these factors in evaluating the statements herein, and not rely on such statements. The forward-looking statements in this release are made as of the date hereof and Nouveau Life Pharmaceuticals.
Looks pretty good M/A/B.
I was checking them out.
Short Squeeze definitely looks underway today!!
Arrayit initiates discussions with advanced bio-based materials and chemistries leaders Poly6 Technologies Boston MA poly6.com
DDDX GREATEST NAKED SHORT SQUEEZE EVERY HERE'S WHY
2014 right after RM Offshore Hedgefund with help form MM spike PPS $7 when 8mfloat NOW .08 only 12mfloat > Fails to Deliver in dollars and no covering as of yet BUT we know DDDX going current anyday and has orders in from BOEING BP and GENERAL DYNAMICS!! Read last PR doing software collaboration with XONE a $13 Nasdaq Co. DDDX is real. In fact, thier 3D Metal cutting machine is State of the Art and offers cost containment to such Co's One will need tickers thou
$$$$ AMFE $$$$
https://investorshub.advfn.com/cannabis-stocks/
#1 pick wins hands down!
ONCI alert! Up 42% pending news! 10 bagger coming
Look at the L2 on ARYC.....Trading at .0068.....10k about to be released. It is a Silicon Valley biotech with a locked float.....Arrayit's products are selling, in the tens of thousands of dollars .... every single day!!
Trading under a penny per share and the float is almost entirely locked. Anyone selling their shares currently has not done any real due diligence on the company. Arrayit has, and is, undergoing drastic changes and is in the process of getting current in their financials using the prestigious audit firm RRBB.
A link to their products list:
http://www.arrayit.com/Products/products.html
look at this one
CACIQUE MINING (GEGI). ANNOUNCES FUTURE PLANS
June 17, 2017
Kate Bahnsen
Cacique Mining (GEGI), announces it has closed on its first mining project. The company announces the Guayuco project based in Colombia. Additionally, the company has made the necessary filling to the State of Nevada, started its process to get current on OTC, and has completed its financials through the first two quarters of 2017. Juan David Perez, CEO, states “ We are extremely excited about this project, and anticipate adding addition projects by the end of 2017. The mining industry is going through a massive expansion in Colombia based on the recent changes in the political and economic climate. This is a great time to be in the mining industry in Colombia. We will continue to update shareholders in the coming weeks, and expect to return to Pink Sheet current in short order.”
Genesis Electronics will change its name to Cacique Mining Inc.
Cacique Mining will continue with the Green Mine Solutions vision of working with the community in green projects. The Guayuco project is a gallery project so it is very important to create job in the community. Cacique Mining Inc. and Green Mine Solutions has enter into an agreement with Inca Worldwide to grow Sacha Inchi on the land above the mine.
”For more information email info@caciquemining.co or visit the company website.
About Cacique Mining
Sustainability of our mining projects is a factor taken very seriously, with both social and environmental care strategically considered. All the properties surrounded by land appropriate for the harvesting of Inca Seeds (Sacha Inchi) and the project will use the knowhow and commercial development of Inca World Wide to utilize this land for the local community.
The project intends to upgrade an existing small mine that extracts gold from Guayuco vein. The actual operation is mining 2 tons of mineral per day and will be upgraded to a medium size mine in a period of seven years. A scoping analysis of the initial project is being developed taking into account only the Guayuco vein given the higher degree of information obtained in the reconnaissance.
Arrayit Corporation (ARYC) leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. - Powerful Science for Life™
$5M credit facility with expected $20M revenues, $2-3M earnings, $60-90M cap and NASDAQ listing.
http://www.arrayit.com/
ARYC
@Arrayit
ARYC is getting ready to be a monster ....... PPS at .0066
Arrayit Corporation
927 Thompson Place
Sunnyvale, CA 94085
USA
Phone 408-744-1331
FAX 408-744-1711
Email arrayit@arrayit.com
Web www.arrayit.com
Subsidiary of ARYC, AVDX,now at .20 puts ARYC's 40mm share ownership at $8 mm, alone. .....
http://www.arrayit.com/
See what’s happening on Twitter:
Arrayit receives $168,000 letter of credit from top microarray technology and life science distributor in South Asia
(link: http://arrayit.com/Products/products.html)
arrayit.com/Products/produ…
Arrayit reports $75,800 microarray services sale to a leading research laboratory focusing on protein networks
(link: http://arrayit.com/Services/services.html)
arrayit.com/Services/servi…
Arrayit reports $100,000+ microarray services sale to a leading US-based research laboratory
(link: http://arrayit.com/Services/services.html)
arrayit.com/Services/servi…
Arrayit wins technical specification bid on $110,000 microarray instrument government tender with top life sciences distributor in India.
Arrayit anticipates significant participation in new congressional proposal for $4.8 billion 21st Century Cures Act
https://www.
genomeweb.com/policy-legisla
tion/congressional-committees-release-final-draft-21st-century-cures-act
…
Arrayit reports $18,500 microarray platform sale life sciences leader ChemBio Moscow Russia
?http://www.?
?chembio.ru?
Arrayit Corporation ??@arrayit?
Arrayit quotes $160,000 microarray platform to molecular diagnostic leader Akonni Biosystems
http://www.
akonni.com
Arrayit quotes $179,430 microarrays to biomedical leader Progenie Molecular Valencia España
http://www.
progenie-molecular.com
Arrayit quotes $51,680 microarrays to top leader De La Salle University Manila Philippines
http://www.
dlsu.edu.ph
Arrayit quotes $102,240 microarray platform to venture think tank Leading Technology Group
http://www.
leadingtechnology.co
Arrayit quotes $38,485 microarray platform to top Korean distributor Daemyung Science Seoul
http://www.
dm4you.com
Arrayit Corporation ??@arrayit?
Arrayit completes conference call on huge DNA testing opportunity in massive market in India
http://
arrayit.com/Services/SNP_G
enotyping/snp_genotyping.html
…
Arrayit reports DNA testing inquiry from top agency in India. Market penetration of 0.1% would produce $48M revenues
http://
arrayit.com/Services/SNP_G
enotyping/snp_genotyping.html
…
Arrayit Corporation ??@arrayit?
Arrayit quotes $235,000 microarray instruments to top lab University Ottawa Ontario Canada
http://www.
uottawa.ca
Arrayit reports microarray sale to advanced technology leaders Waki Company Tokyo Japan
http://
waki-bg.jp
Arrayit reports microarray sale to automated molecular testing leader AutoGenomics Vista CA
?http://www.?
?autogenomics.com?
Arrayit reports microarray sale to life sciences European Biotech Network Dolembreux Belgium
?http://www.?
?euro-bio-net.com?
Arrayit reports microarray sale to top medical researcher at $13.4B endowed MIT Cambridge MA
http://
web.mit.edu
Arrayit expands marketing on $100K+ TissueMax™ Automated and Personal Tissue Microarrayers
http://
arrayit.com/Products/Micro
arrayers/Tissue_Microarrayers/tissue_microarrayers.html
…
Link to their products:
http://www.arrayit.com/Products/products.html
Arrayit has earned respect as a leader in the health care and life sciences industries with its proven expertise in three key areas: the development and support of microarray tools and components, custom printing and analysis of microarrays for research, and the identification and development of diagnostic microarrays and tools for early detection of treatable disease states. As a result, Arrayit has provided tools and services to thousands of the leading genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, government agencies and biotechnology companies worldwide.
Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.
Arrayit customers from Arizona State use Arrayit microarray technology to publish adult stem cell therapy advance
http://www.
sciencedirect.com/science/articl
e/pii/S1873506115000598
…
Can an antibody microarray made with Arrayit technology replace in-situ hybs in HER2 breast cancer diagnostics?...
?http://?
?fb.me/2Xx9b1Oom?
Arrayit reports $18,500 microarray platform sale life sciences leader ChemBio Moscow Russia
http://www.
chembio.ru
$PMCB Promising Growth Potential for Pharmacyte Biotech Inc (OTCMKTS:PMCB)
Pharmacyte Biotech Inc (OTCMKTS:PMCB) is an emerging potential competitor to Ely Lilly (LLY) and its chemotherapy drug, gemcitabine. The stock has certainly had its ups and downs as the company battles for legitimacy with its alternative, which is to use its advanced, inoperable pancreatic cancer therapy, “which consists of the company’s signature live-cell encapsulation technology, Cell-in-a-Box, plus low doses of the FDA-approved chemotherapy drug ifosfamide, in its upcoming clinical trial where it will go head to head with gemcitabine in order to address an unmet medical need.”
In recent action, we’ve witnessed 6% during the past month in terms of shareholder gains in the name. The situation may be worth watching. PMCB is a stock who’s past is littered with sudden rips. Moreover, the name has witnessed a pop in interest, as transaction volume levels have recently pushed 37% over what the stock has registered over the longer term.
Pharmacyte Biotech Inc (OTCMKTS:PMCB) frames itself as a clinical stage biotechnology company that focuses on developing and commercializing treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology, known as Cell-in-a-Box. Its Cell-in-a-Box technology would be used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer, and diabetes.
The company is developing therapies for pancreatic and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of the cancer.
It is also developing a therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes; and examining the benefits of the Cell-in-a-Box technology to develop therapies for cancer-based upon the constituents of the Cannabis plant.
The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was founded in 1996 and is based in Silver Spring, Maryland.
According to company materials, “PharmaCyte Biotech is a clinical stage biotechnology company developing therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as “Cell-in-a-Box®.” This technology will be used as a platform upon which therapies for several types of cancer and diabetes are being developed. PharmaCyte’s therapy for cancer involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active or “cancer-killing” form. These encapsulated cells are implanted as close to the patient’s cancerous tumor as possible. Once implanted, a chemotherapy drug that is normally activated in the liver (ifosfamide) is given intravenously at one-third the normal dose. The ifosfamide is carried by the circulatory system to where the encapsulated cells have been implanted. When the ifosfamide comes in contact with the encapsulated cells they act as an artificial liver and activate the chemotherapy drug at the source of the cancer. This “targeted chemotherapy” has proven effective and safe to use in past clinical trials and results in no side effects.”
The company has been one for frequent road shows and engagements as it seeks to get its message out in what is something of a battle for hearts and minds in the space.
The most recent version of this process is the company’s announcement that its senior management team will attend the 53rd annual meeting of the American Society of Clinical Oncology (ASCO) to be held June 2-6, 2017, at McCormick Place in Chicago. The theme of this year’s meeting is “Making a Difference in Cancer Care with You.”
PharmaCyte’s Chief Executive Officer, Kenneth L. Waggoner, commented, “This year’s annual meeting of ASCO will be our most important as we work towards enrolling the first patient in our planned clinical trial in locally advanced pancreas cancer (LAPC). During this multi-day event, we will be hosting a special meeting of leading clinical oncologists who have expressed interest in participating in our clinical trial. This special meeting is designed to: (i) provide an update on the progress PharmaCyte has made this past year in getting ready for the trial; (ii) provide a timeline for filing the IND and for enrolling the first patient; (iii) make introductions of and allow for comments by key members of PharmaCyte’s Clinical Management Team (Dr. Manuel Hidalgo, Dr. Matthias Löhr, Translational Drug Development (TD2) and Imaging Endpoints, the two major CROs who will be conducting the trial for us); and (iv) gain a commitment from the oncologists and their respective cancer centers to participate in our exciting study.”
#SiliconValley #biotech $ARYC is trading for .0066 per share!! That's less than one penny per share!!......we are waiting on the financial release which should happen within the next 14 days , as we just had 8K's released
Please everyone, do your due diligence on ARYC...... There has been NO increase in OS or AS in the past 16 months and there is great news re sales and contracts. Keep accumulating shares, when financials are released, the stock will go parabolic. Hold your shares and do not even think about selling at low levels like we are at right now. Again, do your due diligence and you'll see what an amazing opportunity we have. I have never seen a company trading at such a low share price with revs/potential as Arrayit. This is due to both of the factors I listed. When one or both of those are addressed ............
Any doubts about the company, you can stop by for a visit if you're on the West Coast.....Google their headquarters. But what you don't see is the brand-new Apple building that is under construction 200 feet away from Arrayit Headquarters!! I've been trading stocks for over 10 years and this is the first company that I have found that is so incredibly undervalued. I'm all in.
Arrayit Corporation
927 Thompson Place
Sunnyvale, CA 94085
USA
Phone 408-744-1331
FAX 408-744-1711
Email arrayit@arrayit.com
Web www.arrayit.com
If you have been following ARYC on L2, you will see that share prices are moving slowly but steadily upwards over the past few months. It is a real company, real products and earnings of $2.3m in 2015 and over $8 million last year!!Please DD and see that ARYC share price has bottomed and a small investment of $5000 could net a return of $100,000 to $500,000. Don't miss opportunity my friends. A lot of money can be made by purchasing shares at this level. Please DD and research what's about to happen here.
http://www.arrayit.com/
A list of Arrayit Corporation patents:
https://t.co/EMXlE743rz
A link to their products:
http://www.arrayit.com/Products/products.html
ARYC also owns 40 million shares of AVDX. A value of $12 million +
Arrayit Corporation (ARYC) @Arrayit leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. - Powerful Science for Life™
Two new contracts totaling approximately $51 million signed!
Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.
Arrayit Corporation: Follow them on Facebook
@Arrayit on Twitter for daily updates
*__* FNHI *__* News states 2 weeks for Audited 10k
Get this low floater @.03 on your watch list now.,
Arrayit confirms strategic conference call today with advanced healthcare research leader Diabetes Relief Houston TX diabetesrelief.com
$ARYC moving up #Siliconvalley
$$$$ UOIP $$$$
MAJOR VICTORIES FOR UOIP/CHANBOND against the Cable Companies!
The Patent Board just ruled in UOIP/CHANBOND's favor over RPX (the cable companies.) This follows their recent win over CISCO!
The court documents listed below show that the neither Cisco or RPX could discredit UOIP's patents.
WHY IS THIS IMPORTANT? In 2015 UOIP/Chanbond filed a lawsuit against the 13 major Cable companies for patent infringement. The cable companies through RPX and Cisco then challenged UOIP's patents with the Patent Board (PTAB). The PTAB not only ruled in UOIP's favor but from reading the documents it looks like CISCO and RPX both were grasping at straws.
These wins are admissible in court! They Cable companies have lost their petitions. If they continue with the court case and lose which is likely given these wins with the PTAB they will lose all leverage in negotiating with UOIP.
A settlement now is the most logical answer!
COURT DOCUMENT Showing win over RPX on 5/25/17
https://s3-us-west-1.amazonaws.com/ptab-filings%2FIPR2016-00234%2F28
Quote:
III. CONCLUSION
For the foregoing reasons, we determine that RPX has not shown by a
preponderance of the evidence that claims 1–31 are unpatentable.
IV. ORDER
It is
ORDERED claims 1–31 of the ’822 patent are not held unpatentable;
and
FURTHER ORDERED that, because this is a Final Written Decision,
parties to the proceeding seeking judicial review of the decision must
comply with the notice and service requirements of 37 C.F.R. § 90.2.
ARTICLE describing recent win over Cisco
http://www.natlawreview.com/article/chanbond-avoids-institution-six-cisco-ipr-petitions
Chanbond lawsuit against the major cable companies listed below.
https://www.pacermonitor.com/case/9426386/ChanBond,_LLC_v_Atlantic_Broadband_Group,_LLC
Atlantic Broadband Group, LLC
Bright House Networks, LLC
CSC Holdings, LLC
Cable One, Inc
Cablevision Systems Corporation
Cequel Communications Holdings I, LLC
Cequel Communications, LLC
Charter Communications, Inc
Comcast Cable Communications, LLC
Comcast Corporation
Cox Communications, Inc.
Mediacom Communications Corporation
RCN Telecom Services, LLC
Time Warner Cable Enterprises LLC
Time Warner Cable Inc.
WaveDivision Holdings, LLC
WideOpen West Finance, LLC
We expect an update on the case by June 12th
Quote:
Tuesday, May 16, 2017
order SO ORDERED Tue 12:05 PM
SO ORDERED, re110 STIPULATION TO EXTEND TIME for the parties to submit a joint status report and proposed revised schedule to June 12, 2017. Signed by Judge Richard G. Andrews on 5/16/2017. (nms)
Note:
Compliments of Gm1850
ARYC: Arrayit Corporation http://arrayit.com
Currently trading at .006... Yet it has estimated revenues last year of over $8 million!
@Arrayit on Twitter
Link to their products:
http://www.arrayit.com/Products/products.html
ARYC also owns 40 million shares of AVDX. A value of $12 million +
Countries who have legalized Marijuana: http://globalnews.ca/news/3378603/marijuana-laws-around-the-world/
$$$$ AMFE $$$$
After Hours news Friday.
6 month report... 2 Quarters of NET profits and massive growth taking place for multiple subs + a shrinking OS...
https://www.otcmarkets.com/stock/AMFE/news/Amfil-Technologies-Inc--Provides-A-Company-Operations-Overview-Of-The-Last-6-Months?id=160275&b=y
Get Summ...
$MACK Big Show By Merrimack Pharmaceuticals, Inc. (MACK), And Its Technical Chart MACK
https://nystocknews.com/2017/05/16/big-show-by-merrimack-pharmaceuticals-inc-mack-and-its-technical-chart/
$PMCB PharmaCyte Biotech Retains Facet Life Sciences to Guide Pancreatic Cancer Therapy Development Lifecycle with FDA PMCB
https://globenewswire.com/news-release/2017/01/30/911996/0/en/PharmaCyte-Biotech-Retains-Facet-Life-Sciences-to-Guide-Pancreatic-Cancer-Therapy-Development-Lifecycle-with-FDA.html
Go $PMCB
$PMCB First Ever Cannabis-Based ETF to Include PharmaCyte Biotech, Abbott Laboratories, and GW Pharmaceuticals PMCB
http://finance.yahoo.com/news/first-ever-cannabis-based-etf-141500085.html
Go $PMCB
HEADS UP$$!! >>>$NSAV Announces 10% Stock Dividend and June 1 Record Date
ESNR Gaining strength. Homeland security.
************ AMFE *************
So let me get this straight, in the past 6 months;
1) The company went from $100k in revenue to $3.5 million in revenue
2) Has 100's of thousands of dollars of net profit
3) Went from 1 to 160 employees
4) Cut the outstanding sharecount almost in half down to 400 million
5) Funding 3rd brick and mortar location AND the GROzone technology WITHOUT any toxic funding
6) Cut deals with 4 different major public companies - Amazon, Cineplex, Indigo Chapters, Nintendo.. all of which are BILLION DOLLAR COMPANIES!!
How is this stock under .10?
In fact can someone PLEASE show me a stock like this under 50 cents?
Compliments of Slambino!
BLVD Thinking we'll see some serious movement upward very soon.
Oh I have some...BLDV...
Thanks RockMan, check out this "Hidden Gem" https://investorshub.advfn.com/Blue-Diamond-Ventures-Inc-BLDV-5566/
.
AMFE .0887 financials this week plus updates on many fronts. So much room for this one to grow. Check out the board for some amazing DD...
Most Posted Cannabis Stocks http://investorshub.advfn.com/cannabis-stocks/ Scroll down there more there than what first appears.
Board Followed..
ARYC ....... Arrayit Corporation is an emerging Biotechnology company in the heart of Silicon Valley.
Arrayit signs $27.1 million term sheet for microarray services with US-based research leader
http://
arrayit.com/Services/servi
ces.html
…
#Arrayit
@Arrayit
www.Arrayit.com
ARYC
An increase in volume will bring ARYC up to .01 this week. ARYC is EXTREMELY undervalued at .0059....... A $10,000 investment could easily turn into $200,000. An increase in volume will cause PPS to go vertical. This is your opportunity
Link to their products:
http://www.arrayit.com/Products/products.html
Arrayit provides additional samples for $2.9 million microarray tech sale to United States Department of Defense DOD
http://www.
defense.gov
Arrayit schedules business development meeting today with top Vietnamese biotech firm regarding $10MM+ potential microarray growth account.
ARYC quotes $16,000,000 microarray services contract to top US-based research laboratory http://arrayit.com/Services/services.html …
ARYC also owns 40 million shares of AVDX. A value of $12 million +
Check out ARYC it's Extremely Undervalued trading at .005.
In anticipation of 3 yr audit being released PTC (Penny Traders Club) members will start promoting ARYC on the 21st of April based on the following.
* Per multiple visit with the CEO, 3 yr audit to be released around 4/30/17.
*Arrayit Corporation is a leading edge developer of next-generation life science tools.
*15 Patents.
*The Company’s patented tools and trade secrets provide researchers around the world.
*Sales reported at ~$30,000 plus every day and growing.
*Estimated revenues last year of over $8 million.
*ARYC has subsidiary AVDX with a 40mm share ownership @ .23 PPS = $9,200,000
This is NOT a P&D company. This is a stock to accumulate for generational wealth. Buying shares sub-penny currently and holding will create immense wealth. There is no reason that it should not be trading over $1 per share. There are no promotions, no paid pumping, ARYC is a real company that is working its way back to the Nasdaq. Grab cheapies while you can!!!!
$PMCB PharmaCyte Biotech Receives the 2017 “Pipelines of Promise” Award from BIO International PMCB
LAGUNA HILLS, Calif., April 19, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that it has received the 2017 Buzz of BIO “Pipelines of Promise” award ahead of the 2017 BIO International Convention. Each year BIO International opens voting for its Buzz of BIO award in two categories, “Pipelines of Promise” and “Technologies of Tomorrow.” The winners are announced ahead of BIO International’s annual convention.
As the winner of the “Pipelines of Promise” award, PharmaCyte will have an opportunity to give a company presentation in the BIO Business Forum in front of industry leaders at the 2017 BIO International Convention, which is being held this year at the San Diego Convention Center in San Diego, California. Also, obtaining the award provides PharmaCyte with access to global biotech and pharma leaders through the BIO One-on-One Partnering™ system, exposure to industry thought-leaders with over 1,500 education sessions and unparalleled networking opportunities with 16,000+ industry leaders from 76 countries. The BIO One-on-One Partnering™ system is the most efficient way to do business in the biotech and pharma industry without traveling all over the world. BIO’s system makes it easy to search for and identify potential partners and request meetings with prospective biotech investors and senior business development executives.
The BIO International Convention attracts 16,000 biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. The Convention brings together a wide spectrum of life science and application areas, including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology and cell therapy.
The 2017 BIO International Convention is the world’s largest biotechnology gathering with tens of thousands of people expected to attend this year’s Convention. It features 1,800 exhibitors and 55 regional and international pavilions, with 8 specialized product focus zones. The BIO International Convention allows companies like PharmaCyte the opportunity to interact with influential decision makers and high-level executives that come to the Convention to discover new therapies in the biotechnology sector, evaluate emerging technologies and form new partnerships.
About PharmaCyte Biotech
PharmaCyte Biotech is a clinical stage biotechnology company developing therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as “Cell-in-a-Box®.” This technology will be used as a platform upon which therapies for several types of cancer and diabetes are being developed. PharmaCyte’s therapy for cancer involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active or “cancer-killing” form. These encapsulated cells are implanted as close to the patient’s cancerous tumor as possible. Once implanted, a chemotherapy drug that is normally activated in the liver (ifosfamide) is given intravenously at one-third the normal dose. The ifosfamide is carried by the circulatory system to where the encapsulated cells have been implanted. When the ifosfamide comes in contact with the encapsulated cells they act as an artificial liver and activate the chemotherapy drug at the source of the cancer. This “targeted chemotherapy” has proven effective and safe to use in past clinical trials and results in no side effects.
In addition to developing a novel therapy for cancer, PharmaCyte is developing a treatment for Type 1 diabetes and insulin-dependent Type 2 diabetes. PharmaCyte plans to encapsulate a human cell line that has been genetically engineered to produce, store and release insulin in response to the levels of blood sugar in the human body. The encapsulation will be done using the Cell-in-a-Box® technology. Once the encapsulated cells are implanted in a diabetic patient they will function as a “bio-artificial pancreas” for purposes of insulin production.
Safe Harbor
This press release contains forward-looking statements, which are generally statements that are not historical facts. Forward-looking statements can be identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans," "will," "outlook" and similar expressions. Forward-looking statements are based on management's current plans, estimates, assumptions and projections, and speak only as of the date they are made. We undertake no obligation to update any forward-looking statement in light of new information or future events, except as otherwise required by law. Forward-looking statements involve inherent risks and uncertainties, most of which are difficult to predict and are generally beyond our control. Actual results or outcomes may differ materially from those implied by the forward-looking statements because of the impact of several risk factors, many of which are discussed in more detail in our Annual Report on Form 10-K and our other reports filed with the Securities and Exchange Commission.
More information about PharmaCyte Biotech can be found at www.PharmaCyte.com. It can also be obtained by contacting Investor Relations.
Contact:
Investor Relations:
PharmaCyte Biotech, Inc.
Investor Relations Department
Telephone: 917.595.2856
Email: Info@PharmaCyte.com
https://globenewswire.com/news-release/2017/04/19/962156/0/en/PharmaCyte-Biotech-Receives-the-2017-Pipelines-of-Promise-Award-from-BIO-International.html
Added KGET 2's on news...no-brainer.
NOUV – Low Float (147M), Monster Upside, OTC Pink Current, Fortune 500 Clients, Who's Who of the World Clients, Government Agency Contracts, Huge insider ownership (83.61%), Super Clean L2, Extremely Thin.
***REVERSE MERGER with ENTUIT INC.***
Jeffrey Burns is the CEO of Entuit Incorporated. He is listed as the CEO of NOUV on OTCMarkets and NVSOS Filings. He is also in all the filings for NOUV to become current with OTCMarkets.
The following was taken from Jeffrey Burns LinkedIn page,
See EntuitInc’s "Who's Who of the World" and "Fortune 500" Client list below.
OTC PINK CURRENT a/o 2/08/2017
http://www.otcmarkets.com/market-activity/otc-tier-changes?search=nouv&searchType=symbol
Verified Company Profile as of 3/28/2017
http://www.otcmarkets.com/stock/NOUV/profile
Merging Company is ENTUITINC, the website is
http://www.entuitinc.com/
Wireless Controls Group is a subsidiary of Entuit Inc., the website is
http://wirelesscontrolsgroup.com/
Green Building Partners, LLC is in partnership with ENTUITINC.
http://www.entuitinc.com/greenbldpartners/
• As of December 31, 2016, there were no trading suspensions, stock splits, dividends, recapitalizations, etc.
• Principal products or services, and their markets;
The Company is a leading developer of hardware solutions for the Municipal Lighting, Building Automation, HVAC, Indoor Lighting, Sub-metering and many other applications. We offer a complete line of wireless control units which fills a unique niche in building automation and energy consumption.
Our products encompass inside and outside lighting, HVAC, advanced metering and various other building automations requirements. The versatility of our system allows all your building needs to be brought under one platform, eliminating the need for several software packages. We provide wireless solutions for Lon Works, BAC Net, Mod Bus and Ethernet. We utilize the Tridium JACE, Niagara Language and Sedona for many of our solutions.
"According to a new report published by Zion Market Research, global energy management systems market was valued at around USD 35.17 billion in 2016 and is expected to reach approximately USD 70.93 billion in 2022, growing at a CAGR of above 12.4% between 2017 and 2022 ."
https://www.zionmarketresearch.com/report/ene...ems-market
"According to Navigant Research, global IEMS revenue is expected to grow from $13.5 billion in 2015 to $35.6 billion in 2024 ."
https://www.navigantresearch.com/research/ind...nt-systems
"According to Navigant Research, Energy Management for Healthcare is Expected to Exceed $2 Billion in Annual Revenue by 2024 ."
http://www.businesswire.com/news/home/2015042...-2-Billion
"According to Pike Research, Energy Management Systems for Commercial Buildings will Garner $67 Billion in Investment by 2020 ."
http://www.businesswire.com/news/home/2009111...-Garner-67
NOUV Security Details:
Market Value: $16,529,999 a/o Apr 04, 2017
Authorized Shares: 4,500,000,000 a/o Jan 25, 2017
Outstanding Shares: 4,349,999,733 a/o Jan 25, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 147,462,475 a/o Mar 31, 2012
http://www.otcmarkets.com/stock/NOUV/profile
Nevada Secretary of State (NVSOS ) Status – ACTIVE
Officers Updated:
Jeffrey Burns – President, Treasurer, Director
Greg Chapman – Secretary
http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=i8rDk6viUlvlSvH3sCERAg%253d%253d&nt7=0
Attorney Letter with Respect to Current Information (Apr 4, 2017)
http://www.otcmarkets.com/financialReportViewer?symbol=NOUV&id=168965
4) Issuance History Control shares (10% or more)
A. The nature of each offering (e.g., Securities Act Rule 504, intrastate, etc.); The shares issued by the Company were issued in accordance with the Securities & Exchange Act section 4(2). Per the terms and conditions of the Agreement and plan of Merger dated December 16, 2016, the following former shareholders of Entuit Incorporated were issued 125,000,000 million shares of the Company’s restricted stock.
Susan Burns - 63,750,000
741 Orange Avenue
Daytona, FL 32114
Jeffrey Burns - 61,250,000
741 Orange Avenue
Daytona, FL 32114
http://www.otcmarkets.com/financialReportViewer?symbol=NOUV&id=167959
11 Filings (2012 thru 2016) with OTCMarkets Since Jan 25, 2017
http://www.otcmarkets.com/stock/NOUV/filings
• Beneficial Shareholders of Greater than Five Percent (5%) is 83.61%
Oxford Industrial Group Inc – 51.44%
Mizata, Inc. – 21%
EMG Marketing Solutions, Inc. – 11.17%
http://www.otcmarkets.com/financialReportViewer?symbol=NOUV&id=168962
Entuit’s Client list includes:
Fort Hood
Fort Benning
Fort Bragg
Fort Irwin
Fort Buchanan in San Juan
Charleston Air Force Base
Department of Defense
Department of Energy
Universal Studios
Busch Gardens – Tampa Bay
SeaWorld Adventure Parks
City of Atlantis, Bahamas
City of Sarasota
City of Chicago
City of Albany
Nestle Purina
Macerich
Ahold
Stop&Shop
Westfield
SUNY – The State University of New York
Jefferson Lab
Turnberry Associates
Seneca – Nation of Indians
Albion Correctional Facility, NY
Comfort Inn
The Fair – The Great New York State Fair
Publix
Stor-All Storage
Gleneagles Country Club
SAIC
GA
Nassau
Nestle Purina Testimonial
"TESTIMONIAL - "The solution worked great. I achieved a 60% reduction in energy consumption the first day. My security group loves it because they can control the lights via their cell phones." - Nick, Nestle Purina"
Green Building Partners, LLC is in partnership with ENTUITINC.
http://www.entuitinc.com/greenbldpartners/
Green Building Partners, LLC' Clients:
SUNY – The State University of New York
SUNY Oneonta – Physical Science Building
SUNY Binghamton – Engineering & Science Building
SUNY Plattsburgh – Hudson Hall
SUNY Binghamton – Center of Excellence Building
SUNY Oswego – Park Hall
City of New York Department of Education
Rochester Genesee Regional Transportation Authority
Energy Modeling Study Point of Use Control of HVAC / lighting / plug loads
The Pines Health Care
Jeffrey Burns is a member of The Building Owners and Managers Association (BOMA) Buffalo. The Building Owners and Managers Association (BOMA) is a non-profit trade association, and a federated chapter of BOMA International. Our membership includes over 120 property professionals consisting of building owners, property managers, developers and other real estate professionals as well as associate members providing services and supplies to the commercial real estate industry. Our members own or manage over 52 million square feet of office, commercial, retail and industrial properties.
http://bomabuffalo.com/news.php#Message_from_the_President___Paul_Muck
FDBL~"The Company's Friendable App enables users to create one-on-one or group-style meetups for food, drinks, live music, or any occasion. Meetups are set up as events by a user and based on a specific user location or desired venue for each."
"Friendable Gets Glowing App Review" http://www.otcmarkets.com/stock/FDBL/news
"Friendable Gets Glowing App Review" http://www.otcmarkets.com/stock/FDBL/news
Friendable Gets Glowing App Review From Influential Journal 'appPicker'
Marketwired MarketwiredJanuary 21, 2016
CAMPBELL, CA--(Marketwired - Jan 21, 2016) - Friendable, Inc. ( OTC PINK : FDBL ) (the "Company") is pleased to announce that the Company has been featured by the influential app industry journal "appPicker," receiving a glowing review about the Friendable app's uniqueness and usefulness.
The article can be viewed in its entirety at the following link:
http://bit.ly/1RM60JQ
"We are extremely pleased to have this tremendous testimonial by one of the most respected voices in the app industry, written by our peers who understand the app market, our specific industry within the app world, and what matters most about Friendable," stated Robert Rositano, Jr., CEO, Friendable, Inc. "They get us."
The article notes Friendable's 'friend first' offering, highlights the app's approach to making connections based on common interests, the ability to create inclusive social events, and to locate and connect with people in your exact area.
The article ends with a summary statement regarding Friendable:
"If you're sick of traditional online dating apps, then you may want to try Friendable as it's definitely something a little bit different. This app focuses on the social aspect of becoming friends with new people in your area as a priority instead of dating. It may lead to more, but the initial connection is more about companionship and friendship. It's a fun, unique concept and definitely worth giving a try."
--- appPicker, January, 2016.
For more information about Friendable, Inc. please visit:
www.Friendable.com
Visit our social media properties at:
Facebook: http://facebook.com/friendable
Twitter: twitter.com/friendableapp
Instagram: instagram.com/friendableapp
About Friendable:
Friendable recognizes that "Everything starts with Friendship" and the way to make connections and meet new people continues to evolve through new technologies and devices that make it all possible. Today just about everyone is on the move and interacting online with their mobile devices, creating dynamic opportunities to find and explore new experiences with location specific accuracy.
Friendable provides its vast mobile community of users with the freedom to meet new people, hang out with current friends, explore exciting venues and interact in social activities based around shared interests and location, transforming mobile interactions into a real-life social experiences. Friendable bridges our mobile community of users with the meeting of new friends, building relationships and connecting them with local venues or events tied to their interests, which presents newfound ways for them to interact and hang out.
Meeting new people and making connections has grown, where the modern meaning of "being social" or "meeting up," now includes opportunities to meet through mobile apps. The result of these interactions produces hyper-local advertising opportunities, allowing Friendable to act as both a friend finder and concierge using nearby locations to identify activities, events and businesses that may provide the entertainment they are seeking.
Making friends through a mobile app allows people of various backgrounds to connect through common interests and engage in fresh experiences while cultivating deep relationships. Meet people where you want, when you want, and show the world that you're Friendable -- Everything starts with friendship!
Join Friendable today and let someone know what you're "Friendable" for!
Cautionary Language Concerning Forward-Looking Statements
This press release contains forward-looking statements. The words or phrases "would be," "will allow," "intends to," "will likely result," "are expected to," "will continue," "is anticipated," "estimate," "project," or similar expressions are intended to identify "forward-looking statements." Actual results could differ materially from those projected by Friendable, Inc. The iTunes rankings should not be construed as an indication in any way whatsoever of the future value of the Friendable's common stock or its present or future financial condition. The public filings of Friendable, Inc. made with the Securities and Exchange Commission may be accessed at the SEC's Edgar system at www.sec.gov. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. Friendable, Inc. cautions readers not to place reliance on such statements. Unless otherwise required by applicable law, Friendable, Inc. does not undertake, and Friendable, Inc. specifically disclaims any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.
Silicon Valley biotech trading at .0051!!!....$ARYC, many updates:
http://twitter.com/arrayit
Arrayit Microsoft array technology customers at Bio-X Stanford University publish next generation sequencing NGS advance
Arrayit reports $16,900 microarray technology sale to a top immunology research laboratory in the Southwestern USA
(link: http://arrayit.com/Services/services.html)
arrayit.com/Services/servi…
Arrayit reports $19,000 microarray technology platform sale to a top European lifestyle and wellness testing company
Arrayit reports microarray technology sale to top life science distribution portal Bio-Connect Huissen Netherlands
Arrayit reports Parkinson's Disease Test PDx™ partnering opportunity with top physician in Molecular Medicine India
Arrayit reports microarray technology sale to top life sciences distribution leaders Probiotek located Laredo Mexico
Arrayit reports microarray technology inquiry top scientist Center Optical Materials Clemson University Anderson SC
Arrayit senior management receives speaking invitation at 15th Annual Drug Discovery Congress Nov 9 2017 Xi’an China
Arrayit reports microarray technology shipping request from healthcare leader Texas Childrens Hospital Houston TX
?@arrayit?
Arrayit reports Parkinson's Disease Test PDx™ partnering opportunity with top physician in Molecular Medicine India
(link: http://nimhans.ac.in)
nimhans.ac.in
Arrayit reports $400,000 microarray services inquiry from advanced pharmaceutical leader Cellceutix CTIX Beverly MA
(link: http://www.cellceutix.com)
cellceutix.com
Arrayit reports $168,000 microarray platform sale to leading medical suppliers Medi Laser located in Lahore Pakistan
(link: http://www.medilaser.com.pk)
medilaser.com.pk
Arrayit Silicon Valley store sales exceed $54 million all-time on 222,269 microarray products and services
http://
shop.arrayit.com
Arrayit receives new financing lead that could generate 6,000 x $100K = $600MM in Arrayit microarray platform sales
http://
arrayit.com
Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.
http://www.medgadget.com/2017/01/recent-report-covers-upcoming-opportunities-in-array-instruments-market-technologies-dna-microarrays.html
Arrayit Corporation ?@arrayit
Arrayit quotes $16,000,000 microarray services contract to top US-based research laboratory http://arrayit.com/Services/services.html …
Arrayit backorders soar to record $2.5MM on strong demand for microarray products & services
http://
arrayit.com/index.html
Arrayit Corporation
http://www.arrayit.com/
Check out their Facebook page: Arrayit Corporation
Follow $ARYC on Twitter @Arrayit
Avant Diagnostics, Inc. provide the market’s first large panel biomarker monitoring test for ovarian cancer (OVC). OvaDx® is advanced microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA approval, Avant will offer OvaDx® as an elective test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. OvaDx® will be used by doctors to advance the forefront of ovarian cancer treatment including improved surgical options, more effective chemotherapies, and to supplement existing tests including CA-125, OVA1®, and transvaginal ultrasound.
Arrayit manufacturing team completes 20,000 blood card production run with $6.9M 2017 life science revenue potential
(link: http://arrayit.com/Products/Protein_Microarrays/Blood_Card/blood_card.html)
arrayit.com/Products/Prote…
$NOUV – The CEO is working with Fortune 500 Clients, Who's Who of the World Clients, Government Agency Contracts, Monster Upside, OTC Pink Current, Huge insider ownership (83.61%), Super Clean L2, Extremely Thin, Low Float (147M).
***REVERSE MERGER with ENTUIT INC.***
Jeffrey Burns is the CEO of Entuit Incorporated. He is listed as the CEO of NOUV on OTCMarkets and NVSOS Filings. He is also in all the filings for NOUV to become current with OTCMarkets.
The following was taken from Jeffrey Burns LinkedIn page,
See EntuitInc’s "Who's Who of the World" and "Fortune 500" Client list below.
OTC PINK CURRENT a/o 2/08/2017
http://www.otcmarkets.com/market-activity/otc-tier-changes?search=nouv&searchType=symbol
Verified Company Profile as of 3/28/2017
http://www.otcmarkets.com/stock/NOUV/profile
Merging Company is ENTUITINC, the website is
http://www.entuitinc.com/
Wireless Controls Group is a subsidiary of Entuit Inc., the website is
http://wirelesscontrolsgroup.com/
Green Building Partners, LLC is in partnership with ENTUITINC.
http://www.entuitinc.com/greenbldpartners/
• As of December 31, 2016, there were no trading suspensions, stock splits, dividends, recapitalizations, etc.
• Principal products or services, and their markets;
The Company is a leading developer of hardware solutions for the Municipal Lighting, Building Automation, HVAC, Indoor Lighting, Sub-metering and many other applications. We offer a complete line of wireless control units which fills a unique niche in building automation and energy consumption.
Our products encompass inside and outside lighting, HVAC, advanced metering and various other building automations requirements. The versatility of our system allows all your building needs to be brought under one platform, eliminating the need for several software packages. We provide wireless solutions for Lon Works, BAC Net, Mod Bus and Ethernet. We utilize the Tridium JACE, Niagara Language and Sedona for many of our solutions.
"According to a new report published by Zion Market Research, global energy management systems market was valued at around USD 35.17 billion in 2016 and is expected to reach approximately USD 70.93 billion in 2022, growing at a CAGR of above 12.4% between 2017 and 2022 ."
https://www.zionmarketresearch.com/report/ene...ems-market
"According to Navigant Research, global IEMS revenue is expected to grow from $13.5 billion in 2015 to $35.6 billion in 2024 ."
https://www.navigantresearch.com/research/ind...nt-systems
"According to Navigant Research, Energy Management for Healthcare is Expected to Exceed $2 Billion in Annual Revenue by 2024 ."
http://www.businesswire.com/news/home/2015042...-2-Billion
"According to Pike Research, Energy Management Systems for Commercial Buildings will Garner $67 Billion in Investment by 2020 ."
http://www.businesswire.com/news/home/2009111...-Garner-67
NOUV Security Details:
Market Value: $16,529,999 a/o Apr 04, 2017
Authorized Shares: 4,500,000,000 a/o Jan 25, 2017
Outstanding Shares: 4,349,999,733 a/o Jan 25, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 147,462,475 a/o Mar 31, 2012
http://www.otcmarkets.com/stock/NOUV/profile
Nevada Secretary of State (NVSOS ) Status – ACTIVE
Officers Updated:
Jeffrey Burns – President, Treasurer, Director
Greg Chapman – Secretary
http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=i8rDk6viUlvlSvH3sCERAg%253d%253d&nt7=0
Attorney Letter with Respect to Current Information (Apr 4, 2017)
http://www.otcmarkets.com/financialReportViewer?symbol=NOUV&id=168965
4) Issuance History Control shares (10% or more)
A. The nature of each offering (e.g., Securities Act Rule 504, intrastate, etc.); The shares issued by the Company were issued in accordance with the Securities & Exchange Act section 4(2). Per the terms and conditions of the Agreement and plan of Merger dated December 16, 2016, the following former shareholders of Entuit Incorporated were issued 125,000,000 million shares of the Company’s restricted stock.
Susan Burns - 63,750,000
741 Orange Avenue
Daytona, FL 32114
Jeffrey Burns - 61,250,000
741 Orange Avenue
Daytona, FL 32114
http://www.otcmarkets.com/financialReportViewer?symbol=NOUV&id=167959
11 Filings (2012 thru 2016) with OTCMarkets Since Jan 25, 2017
http://www.otcmarkets.com/stock/NOUV/filings
• Beneficial Shareholders of Greater than Five Percent (5%) is 87.35%
Oxford Industrial Group Inc – 51.44%
Mizata, Inc. – 21%
EMG Marketing Solutions, Inc. – 11.17%
http://www.otcmarkets.com/financialReportViewer?symbol=NOUV&id=168962
Entuit’s Client list includes:
Fort Hood
Fort Benning
Fort Bragg
Fort Irwin
Fort Buchanan in San Juan
Charleston Air Force Base
Department of Defense
Department of Energy
Universal Studios
Busch Gardens – Tampa Bay
SeaWorld Adventure Parks
City of Atlantis, Bahamas
City of Sarasota
City of Chicago
City of Albany
Nestle Purina
Macerich
Ahold
Stop&Shop
Westfield
SUNY – The State University of New York
Jefferson Lab
Turnberry Associates
Seneca – Nation of Indians
Albion Correctional Facility, NY
Comfort Inn
The Fair – The Great New York State Fair
Publix
Stor-All Storage
Gleneagles Country Club
SAIC
GA
Nassau
Nestle Purina Testimonial
"TESTIMONIAL - "The solution worked great. I achieved a 60% reduction in energy consumption the first day. My security group loves it because they can control the lights via their cell phones." - Nick, Nestle Purina"
Green Building Partners, LLC is in partnership with ENTUITINC.
http://www.entuitinc.com/greenbldpartners/
Green Building Partners, LLC' Clients:
SUNY – The State University of New York
SUNY Oneonta – Physical Science Building
SUNY Binghamton – Engineering & Science Building
SUNY Plattsburgh – Hudson Hall
SUNY Binghamton – Center of Excellence Building
SUNY Oswego – Park Hall
City of New York Department of Education
Rochester Genesee Regional Transportation Authority
Energy Modeling Study Point of Use Control of HVAC / lighting / plug loads
The Pines Health Care
Jeffrey Burns is a member of The Building Owners and Managers Association (BOMA) Buffalo. The Building Owners and Managers Association (BOMA) is a non-profit trade association, and a federated chapter of BOMA International. Our membership includes over 120 property professionals consisting of building owners, property managers, developers and other real estate professionals as well as associate members providing services and supplies to the commercial real estate industry. Our members own or manage over 52 million square feet of office, commercial, retail and industrial properties.
http://bomabuffalo.com/news.php#Message_from_the_President___Paul_Muck
CGAC: Latest shareholder update!
https://finance.yahoo.com/news/code-green-apparel-corp-shareholder-164500042.html
*** CGAC ***
.0072 ~> Provides corporate apparel to 7-11 and On the Boarder Restaurants
Followers
|
51
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1480
|
Created
|
02/06/17
|
Type
|
Free
|
Moderators neophyte184 PennyStock Alert Hunchbackgeek CHIEF-RISES-ABOVE $Pistol Pete$ |
Posts Today
|
0
|
Posts (Total)
|
1480
|
Posters
|
|
Moderators
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |